Pee test could replace scopes for bladder cancer monitoring
Diagnosis
Recruiting now
This study is testing BCDx, a urine-based test designed to detect the return of non-muscle invasive bladder cancer (NMIBC) earlier and without a scope. Researchers will enroll 500 people with a history of NMIBC and compare the test's accuracy to standard cystoscopy. If it works, …
Sponsor: Early is Good Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC